176 related articles for article (PubMed ID: 19299772)
41. Bivalirudin anticoagulation during cardiac surgery: a single-center experience in 141 patients.
Koster A; Buz S; Krabatsch T; Yeter R; Hetzer R
Perfusion; 2009 Jan; 24(1):7-11. PubMed ID: 19567542
[TBL] [Abstract][Full Text] [Related]
42. Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant.
Krolick MA
Haemophilia; 2005 Jul; 11(4):415-7. PubMed ID: 16011598
[TBL] [Abstract][Full Text] [Related]
43. Routine use of the direct thrombin inhibitor bivalirudin for off-pump coronary artery bypass grafting is safe and effective.
Palmer GJ; Sankaran IS; Sparkman GM; Koster A; Dyke CM; Ebra G
Heart Surg Forum; 2008; 11(1):E24-9. PubMed ID: 18270134
[TBL] [Abstract][Full Text] [Related]
44. An assay to monitor bivalirudin levels on cardiopulmonary bypass.
Salemi A; Agrawal YP; Fontes MA
Ann Thorac Surg; 2011 Jul; 92(1):332-4. PubMed ID: 21718867
[TBL] [Abstract][Full Text] [Related]
45. Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
Gurm HS; Smith DE; Chetcuti SJ; Share D; Khanal S; Riba A; Carter AJ; Lalonde T; Kline-Rogers E; O'Donnell M; O'Neill W; Safian R; Moscucci M;
J Interv Cardiol; 2007 Jun; 20(3):197-203. PubMed ID: 17524111
[TBL] [Abstract][Full Text] [Related]
46. Recognition and management of heparin-induced thrombocytopenia in pediatric cardiopulmonary bypass patients.
Boshkov LK; Kirby A; Shen I; Ungerleider RM
Ann Thorac Surg; 2006 Jun; 81(6):S2355-9. PubMed ID: 16731103
[TBL] [Abstract][Full Text] [Related]
47. Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.
Chamberlin JR; Lewis B; Leya F; Wallis D; Messmore H; Hoppensteadt D; Walenga JM; Moran S; Fareed J; McKiernan T
Can J Cardiol; 1995 Jun; 11(6):511-4. PubMed ID: 7780873
[TBL] [Abstract][Full Text] [Related]
48. Heparin induced thrombocytopenia management with bivalirudin.
Meera R; Rachel D; Ramakrishnapillai V; Vijayaraghavan G
Indian Heart J; 2007; 59(4):354-5. PubMed ID: 19126942
[TBL] [Abstract][Full Text] [Related]
49. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
Lincoff AM; Bittl JA; Kleiman NS; Sarembock IJ; Jackman JD; Mehta S; Tannenbaum MA; Niederman AL; Bachinsky WB; Tift-Mann J; Parker HG; Kereiakes DJ; Harrington RA; Feit F; Maierson ES; Chew DP; Topol EJ;
Am J Cardiol; 2004 May; 93(9):1092-6. PubMed ID: 15110198
[TBL] [Abstract][Full Text] [Related]
50. Heparin-induced thrombocytopenia and cardiovascular patients: recognition and treatment.
Baker KM; Flattery MP
Prog Cardiovasc Nurs; 2006; 21(1):47-50. PubMed ID: 16522970
[No Abstract] [Full Text] [Related]
51. A modified technique for implantation of the HeartWare™ left ventricular assist device when using bivalirudin anticoagulation in patients with acute heparin-induced thrombocytopenia.
Morshuis M; Boergermann J; Gummert J; Koster A
Interact Cardiovasc Thorac Surg; 2013 Aug; 17(2):225-6. PubMed ID: 23628649
[TBL] [Abstract][Full Text] [Related]
52. Coronary artery bypass grafting in patients with cerebrovascular disease.
Lazar HL; Menzoian JO
Ann Thorac Surg; 1998 Sep; 66(3):968-74. PubMed ID: 9768976
[TBL] [Abstract][Full Text] [Related]
53. Carotid angioplasty in asymptomatic patients undergoing CABG surgery.
Polydorou AD; Megaloikonomos P; Moutiris JA; Polydorou V; Antypa E; Testembasi E; Tziakouri CH; Palatianos G; Nikas D; Bolos K; Polydorou A
Int Angiol; 2010 Jun; 29(3):239-43. PubMed ID: 20502410
[TBL] [Abstract][Full Text] [Related]
54. Anticoagulation with temporary Impella device in patients with heparin-induced thrombocytopenia: A case series.
Hohlfelder B; Militello MA; Tong MZ; Soltesz EG; Wanek MR
Int J Artif Organs; 2021 May; 44(5):367-370. PubMed ID: 33050762
[TBL] [Abstract][Full Text] [Related]
55. Heparin-induced thrombocytopenia presenting with thrombosis of multiple saphenous vein grafts and myocardial infarction.
Ayala E; Rosado MF; Morgensztern D; Kharfan-Dabaja MA; Byrnes JJ
Am J Hematol; 2004 Aug; 76(4):383-5. PubMed ID: 15282674
[TBL] [Abstract][Full Text] [Related]
56. Bivalirudin for Cardiopulmonary Bypass in the Setting of Heparin-Induced Thrombocytopenia and Combined Heart and Kidney Transplantation-Diagnostic and Therapeutic Challenges.
Choxi AA; Patel PA; Augoustides JG; Benitez-Lopez J; Gutsche JT; Murad H; Rodriguez-Blanco YF; Fabbro M; Crookston KP; Gerstein NS
J Cardiothorac Vasc Anesth; 2017 Feb; 31(1):354-364. PubMed ID: 27746016
[No Abstract] [Full Text] [Related]
57. Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass.
Davis Z; Anderson R; Short D; Garber D; Valgiusti A
Ann Thorac Surg; 2003 Jan; 75(1):264-5. PubMed ID: 12537226
[TBL] [Abstract][Full Text] [Related]
58. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
[TBL] [Abstract][Full Text] [Related]
59. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
[No Abstract] [Full Text] [Related]
60. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Ortel TL
Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
